Inhibitory effect of curcumin on uterine leiomyoma cell proliferation

References

• WilcoxLS, KooninLM, PokrasR, StraussLT, XiaZ, PetersonHB. Hysterectomy in the United States, 1988–1990. Obstet Gynecol 1994;83:549–555.
   PubMed Web of Science ®Google Scholar
• LepineLA, HillisSD, MarchbanksPA, KooninLM, MorrowB, KiekeBA, WilcoxLS. Hysterectomy surveillance – United States, 1980–1993. MMWR CDC Surveill Summ 1997;46:1–15.
   PubMedGoogle Scholar
• WalkerCL, StewartEA. Uterine fibroids: the elephant in the room. Science 2005;308:1589–1592.
   PubMed Web of Science ®Google Scholar
• MukhopadhyayA, BanerjeeS, StaffordLJ, XiaC, LiuM, AggarwalBB. Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation. Oncogene 2002;21:8852–6881.
   PubMed Web of Science ®Google Scholar
• SoudaminiKK, UnnikrishnanMC, SoniKB, KuttanR. Inhibition of lipid peroxidation and cholesterol levels in mice by curcumin. Indian J Physiol Pharmacol 1992;36:239–243.
   PubMedGoogle Scholar
• AsaiA, MiyazawaT. Dietary curcuminoids prevent high-fat diet-induced lipid accumulation in rat liver and epididymal adipose tissue. J Nutr 2001;131:2932–2935.
   PubMed Web of Science ®Google Scholar
• SrivastavaR, DikshitM, SrimalRC, DhawanBN. Anti-thrombotic effect of curcumin. Thromb Res 1985;40:413–417.
   PubMed Web of Science ®Google Scholar
• VenkatesanN. Curcumin attenuation of acute adriamycin myocardial toxicity in rats. Br J Pharmacol 1998;124:425–427.
   PubMed Web of Science ®Google Scholar
• AggarwalBB, KumarA, BhartiAC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 2003;23:363–398.
   PubMed Web of Science ®Google Scholar
• AnandP, SundaramC, JhuraniS, KunnumakkaraAB, AggarwalBB. Curcumin and cancer: an “old-age” disease with an “age-old” solution. Cancer Lett 2008;267:133–164.
   PubMed Web of Science ®Google Scholar
• GoelA, KunnumakkaraAB, AggarwalBB. Curcumin as “Curecumin”: from kitchen to clinic. Biochem Pharmacol 2008;75:787–809.
   PubMed Web of Science ®Google Scholar
• KunnumakkaraAB, AnandP, AggarwalBB. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett 2008;269:199–225.
   PubMed Web of Science ®Google Scholar
• EpsteinJ, SandersonIR, MacdonaldTT. Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies. Br J Nutr 2010;103:1–13.
   PubMedGoogle Scholar
• XuJ, FuY, ChenA. Activation of peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth. Am J Physiol Gastrointest Liver Physiol 2003;285:G20–G30.
   PubMed Web of Science ®Google Scholar
• ChenA, XuJ. Activation of PPAR{γ} by curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFR. Am J Physiol Gastrointest Liver Physiol 2005;288:G447–G456.
   PubMed Web of Science ®Google Scholar
• MalikM, MendozaM, PaysonM, CatherinoWH. Curcumin, a nutritional supplement with antineoplastic activity, enhances leiomyoma cell apoptosis and decreases fibronectin expression. Fertil Steril 2009;91:2177–2184.
   PubMed Web of Science ®Google Scholar
• HoustonKD, CoplandJA, BroaddusRR, GottardisMM, FischerSM, WalkerCL. Inhibition of proliferation and estrogen receptor signaling by peroxisome proliferator-activated receptor γ ligands in uterine leiomyoma. Cancer Res 2003;63:1221–1227.
   PubMed Web of Science ®Google Scholar
• WrightHM, ClishCB, MikamiT, HauserS, YanagiK, HiramatsuR, SerhanCN, SpiegelmanBM. A synthetic antagonist for the peroxisome proliferator-activated receptor γ inhibits adipocyte differentiation. J Biol Chem 2000;275:1873–1877.
   PubMed Web of Science ®Google Scholar
• SharmaAM, StaelsB. Review: peroxisome proliferator-activated receptor γ and adipose tissue – understanding obesity-related changes in regulation of lipid and glucose metabolism. J Clin Endocrinol Metab 2007;92:386–395.
   PubMed Web of Science ®Google Scholar
• TakedaT, SakataM, IsobeA, MiyakeA, NishimotoF, OtaY, KamiuraS, KimuraT. Relationship between metabolic syndrome and uterine leiomyomas: a case–control study. Gynecol Obstet Invest 2008;66:14–17.
   PubMed Web of Science ®Google Scholar
• WahlstromB, BlennowG. A study on the fate of curcumin in the rat. Acta Pharmacol Toxicol (Copenh) 1978;43:86–92.
   PubMedGoogle Scholar
• RavindranathV, ChandrasekharaN. Absorption and tissue distribution of curcumin in rats. Toxicology 1980;16:259–265.
   PubMed Web of Science ®Google Scholar
• ShobaG, JoyD, JosephT, MajeedM, RajendranR, SrinivasPS. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med 1998;64:353–356.
   PubMed Web of Science ®Google Scholar
• PanMH, HuangTM, LinJK. Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Dispos 1999;27:486–494.
   PubMed Web of Science ®Google Scholar
• CenL, HutzenB, BallS, DeAngelisS, ChenCL, FuchsJR, LiC, LiPK, LinJ. New structural analogues of curcumin exhibit potent growth suppressive activity in human colorectal carcinoma cells. BMC Cancer 2009;9:99.
   PubMedGoogle Scholar
• ShibataH, YamakoshiH, SatoA, OhoriH, KakudoY, KudoC, TakahashiY, WatanabeM, TakanoH, IshiokaC, et al Newly synthesized curcumin analog has improved potential to prevent colorectal carcinogenesis in vivo. Cancer Sci 2009;100:956–960.
   PubMed Web of Science ®Google Scholar
• MohandasKM, DesaiDC. Epidemiology of digestive tract cancers in India. V. Large and small bowel. Indian J Gastroenterol 1999;18:118–121.
   PubMedGoogle Scholar